BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2821605)

  • 1. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.
    Rothberg PG
    Semin Surg Oncol; 1987; 3(3):152-8. PubMed ID: 2821605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.
    Erisman MD; Scott JK; Astrin SM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4264-8. PubMed ID: 2542967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-myc oncogene expression in colorectal cancer.
    Sikora K; Chan S; Evan G; Gabra H; Markham N; Stewart J; Watson J
    Cancer; 1987 Apr; 59(7):1289-95. PubMed ID: 3545431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme.
    Hamilton SR
    J Cell Biochem Suppl; 1992; 16G():41-6. PubMed ID: 1335099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli.
    Sugio K; Kurata S; Sasaki M; Soejima J; Sasazuki T
    Cancer Res; 1988 Sep; 48(17):4855-61. PubMed ID: 2842040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
    Smith DR; Myint T; Goh HS
    Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of chromosome 6 allele loss in human colorectal carcinomas.
    Wildrick DM; Alfaro SR; Gope R; Boman BM
    Anticancer Res; 1992; 12(5):1717-9. PubMed ID: 1332582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.
    Sundaresan V; Forgacs IC; Wight DG; Wilson B; Evan GI; Watson JV
    J Clin Pathol; 1987 Nov; 40(11):1274-81. PubMed ID: 2826545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene expression in patients with familial polyposis coli/Gardner's syndrome.
    Yuwono M; Rossi TM; Fisher JE; Tjota A
    Int Arch Allergy Immunol; 1996 Sep; 111(1):89-95. PubMed ID: 8753850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
    Yuasa Y; Oto M; Sato C; Miyaki M; Iwama T; Tonomura A; Namba M
    Jpn J Cancer Res; 1986 Sep; 77(9):901-7. PubMed ID: 3021699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
    Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
    Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
    Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.
    Erisman MD; Rothberg PG; Diehl RE; Morse CC; Spandorfer JM; Astrin SM
    Mol Cell Biol; 1985 Aug; 5(8):1969-76. PubMed ID: 3837853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
    Jones DJ; Ghosh AK; Moore M; Schofield PF
    Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and environmental factors in colorectal cancer. Mutations in the familial adenomatous polyposis gene].
    Steffensen IL; Paulsen JE; Alexander J
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2046-51. PubMed ID: 9235686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
    Nishisho I; Nakamura Y; Miyoshi Y; Miki Y; Ando H; Horii A; Koyama K; Utsunomiya J; Baba S; Hedge P
    Science; 1991 Aug; 253(5020):665-9. PubMed ID: 1651563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.